| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |